CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Lansen Pharmaceutical Holdings Limited Company Snapshot
Lansen Pharmaceutical Holdings Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lansen Pharmaceutical Holdings Limited with three other companies in this sector in CHINA : Fujian Cosunter Pharmaceutical Co Ltd (2019 sales of 414.86 million Chinese Renmimbi [US$61.26 million] of which 100% was Medicine), Jiangxi Synergy Pharmaceutical Co Ltd (413.06 million Chinese Renmimbi [US$61.00 million] of which 100% was Pharmaceutical manufacture), and Wuhan Hvsen Biotechnology Co Ltd (427.22 million Chinese Renmimbi [US$63.09 million] of which 26% was Acetylisovaleryltylosin Tartrate).

Sales Analysis. During the year ended December of 2019, sales at Lansen Pharmaceutical Holdings Limited were 428.60 million Chinese Renmimbi (US$63.29 million). This is an increase of 13.8% versus 2018, when the company's sales were 376.56 million Chinese Renmimbi. Despite this increase, sales are still well below the level achieved in 2017, when Lansen Pharmaceutical Holdings Limited reported sales of 602.67 million Chinese Renmimbi. Sales of Specialty Pharmaceuticals saw an increase of 9.6% in 2019, from 318.18 million Chinese Renmimbi to 348.68 million Chinese Renmimbi. Not all segments of Lansen Pharmaceutical Holdings Limited experienced an increase in sales in 2019: sales of Medical Cosmetics Produts fell 91.8% to 1.28 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Lansen Pharmaceutical Holdings Limited also experienced decreases in sales in Healthcare Products (down 43.1% to 24.39 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Lansen Pharmaceutical Holdings Limited
  Stock Performance Chart for Lansen Pharmaceutical Holdings Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): .66
(Figures in Chinese Renmimbi)
1 Week -3.4%   13 Weeks -2.1%  
4 Weeks 7.0%   52 Weeks -13.7%  
 
Lansen Pharmaceutical Holdings Limited Key Data:
  Ticker: 503 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 428,598,288
(Year Ending Jan 2020).
Employees: 624
  Currency: Chinese Renmimbi Market Cap: 263,757,953
  Fiscal Yr Ends: December Shares Outstanding: 397,172,000
  Share Type: H Gu Closely Held Shares: 209,920,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.